News

Encouraging Interim Trial Results Reported for Tesomet in Prader-Willi Patients

Saniona recently reported encouraging results from its exploratory Phase 2a clinical trial evaluating Tesomet (tesofensine/metoprolol) in patients with Prader-Willi syndrome (PWS). PWS is a genetic disorder that begins in childhood. People with Prader-Willi syndrome always feel hungry, which can often lead to obesity and type 2…

Levels of Formerly Silent Genes in Prader-Willi Syndrome Restored in Lab

A team of researchers was able to restore the normal level of genes that are usually silenced in Prader-Willi syndrome (PWS) in patient neurons grown in the lab. The study, led by researchers at the University of Connecticut, is titled “Zinc finger protein 274 regulates imprinted expression…